(Yicai Global) July 7 -- Shanghai-based medical laboratory integrated services provider Runda Medical Science and Technology Co. [SH:603108] will buy equity in two medical services companies as stepping stones to the Northeast China market.

The deal will cement the company's leading position as a provider of in-vitro diagnostic devices and services, and brace the comprehensive service capability of its medical laboratory.

On July 5, the company outed its proposal to buy 60 percent of the equity of Changchun Jinzerui Medical Technology Co. for USD135 million (CNY903 million) and its plan to invest CNY92.96 million to buy 45 percent of the equity of Shanghai Ruimei Computer Technology Co. and thereby become its largest shareholder.

Changchun Jinzerui is a main distributor of Roche Holding AG [VTX: ROG] immunology category products and some products of Sysmex Corp. [TYO: 6869] in Northeast China, the notice said.

Ruimei Technology develops software for information management in the medical industry, particularly Laboratory Information System (LIS) and Blood Information System (BIS) applications. This acquisition will thus prove decisive in consummating the concern's complete informationization, the announcement further asserted.